Delivery Order SPE2DB22D1017-SPE2DB24FG1AJ

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,072.32, is for the delivery of Jardiance 25 mg tablets. The award is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of 90 tablets of the prescription drug Jardiance 10 mg. The firm-fixed-price contract has a ceiling value of $23,450.17 and an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and this award is not associated with a set-aside program. The delivery order is part of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.78, is for the supply of Jardiance 10 mg tablets. The contract is a Firm Fixed Price, Delivery Order contract type and has an ultimate completion date of March 18, 2025. This appears to be an open competition contract, as it does not have a set-aside designation. AmerisourceBergen holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 25 mg tablets, a diabetes medication. The award has a ceiling value of $5,185.38 and a period of performance through April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,740.66, is for the delivery of Jardiance 10 mg tablets. The contract is a firm fixed-price delivery order with a completion date of December 14, 2023. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,266.27, is for the delivery of Jardiance 25 mg tablets. The contract has an ultimate completion date of January 2, 2024 and a firm fixed price pricing type. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,575.14, is for the delivery of Jardiance 25 mg tablets over the performance period ending on April 21, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $73,824.94 firm-fixed-price contract is for the delivery of 4,568,062,245 units of the prescription medication Jardiance 10 mg tablets. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,752.55, is for the delivery of Jardiance 10 mg tablets over the period ending on April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,824.35, is for the delivery of Jardiance 25 mg tablets. It is a firm-fixed-price contract with a period of performance through January 31, 2025. This appears to be an open competition contract, as no set-aside designation is mentioned. AmerisourceBergen holds a significant...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG1AJ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,165.95, is for the delivery of Jardiance 25 mg tablet medication. The award has an ultimate completion date of July 11, 2024 and is a firm fixed-price contract. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:56 AM